These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2273661)

  • 21. [Diagnostic usefulness of Ca 19-9 antigen in cancer of the pancreas and neoplasms of the pancreato-biliary intersection].
    Robles-Diáz G; Aceves G; Galván E
    Gac Med Mex; 1990; 126(2):78-82; discussion 82-3. PubMed ID: 2387490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevation of a tumor associated antigen CA 19-9 levels in patients with rheumatic diseases.
    Shimomura C; Eguchi K; Kawakami A; Migita K; Nakao H; Otsubo T; Ueki Y; Tezuka H; Yamashita S; Matsunaga M
    J Rheumatol; 1989 Nov; 16(11):1410-5. PubMed ID: 2600938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal sarcoidosis and elevated CA 125.
    Trimble EL; Saigo PE; Freeberg GW; Rubin SC; Hoskins WJ
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):976-7. PubMed ID: 1923245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CA 50: a tumor marker for gastrointestinal malignancies.
    Bunworasate U; Voravud N
    J Med Assoc Thai; 1995 May; 78(5):255-70. PubMed ID: 7561549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of CA 50 in nonmalignant liver diseases: a clinical and biochemical study.
    Collazos J; Genolla J; Ruibal A
    Am J Gastroenterol; 1993 Mar; 88(3):409-12. PubMed ID: 8438849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
    Spila A; Roselli M; Cosimelli M; Ferroni P; Cavaliere F; Arcuri R; Tedesco M; Carlini S; D'Alessandro R; Perri P; Casciani CU; Greiner JW; Schlom J; Guadagni F
    Anticancer Res; 1996; 16(4B):2241-7. PubMed ID: 8694550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H; Kaya M; Cengiz A
    Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery].
    Sakurai Y; Kodaira S; Teramoto T; Sugano K; Abe O; Ohtake H; Iri H
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3205-12. PubMed ID: 2782914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung.
    Marechal F; Berthiot G; Deltour G
    Anticancer Res; 1988; 8(4):677-80. PubMed ID: 3178158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A; Kessler AC
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on spatial vector analysis of electrocardiogram in chronic pulmonary disease].
    Okada T
    Jpn Circ J; 1965 Oct; 29(10):959-69. PubMed ID: 5897876
    [No Abstract]   [Full Text] [Related]  

  • 37. [Increased serum CA 19.9 in bronchiectasis].
    Yango J; Pieters T; Coche E; Lambert M
    Rev Mal Respir; 2008 Jan; 25(1):78-81. PubMed ID: 18288056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Marker CA 125 in the Diagnosis of Active Pulmonary Tuberculosis - A Study of Adults in Mostar, B&H.
    Mikačić M; Vasilj I; Vasilj M; Bevanda D; Šimović M; Galić K
    Psychiatr Danub; 2017 Dec; 29 Suppl 4(Suppl 4):841-844. PubMed ID: 29278633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary tumourlets.
    Teppo L; Luosto R
    Ann Chir Gynaecol Fenn; 1975; 64(1):47-9. PubMed ID: 1155903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign Hydronephrosis and Elevated of Serum Levels of Carbohydrate Antigen CA 19-9: A Case Report.
    Filipovic B; Milinić N; Gacic J; Markovic O; Djokovic A; Filipovic B
    Am J Case Rep; 2016 Jun; 17():395-7. PubMed ID: 27287959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.